Updated Jul 16, 2026
O'Rourke Peter has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Peter O'Rourke is listed as a director of Profusa, Inc. (PFSA) in the company's SEC filings as of January 29, 2026. Profusa is a clinical-stage digital health and medical technology company focused on biosensing solutions. The SEC filing indicates his role as a director with no reported purchases or sales in the filing period.
| Role | Director |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-31 | PFSA | Profusa, Inc. | J — Other acquisition / disposition | 107.8K | — |
Peter O'Rourke is listed as a director of Profusa, Inc. (PFSA) in the company's SEC filings as of January 29, 2026. Profusa is a clinical-stage digital health and medical technology company focused on biosensing solutions. The SEC filing indicates his role as a director with no reported purchases or sales in the filing period.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live O'Rourke Peter profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.